Editor's Blog

RSS

Features

There’s a quietly emerging niche in the healthcare industry: social listening for marketable data. But is it moral? And is it safe? Read more

Editor's Blog

Online editor Dave Gray looks back on the conclusion of GSK's turbulence in China, and asks what impact this will have on pharma trading around the world. Read more

Editor's Blog

Lu Rahman, EPM group editor, discusses issues surrounding antibiotic resistance Read more

Editor's Blog

The UK’s largest drug maker AstraZeneca yesterday rejected a second takeover bid of £60 billion from US rival Pfizer, the first being £58.8 billion and made in January. AstraZeneca said it had rejected the offers on account of their “very... Read more

Editor's Blog

It is a year since I first spoke to I Holland Ltd’s research, development & quality systems manager Rob Blanchard about I Holland and the University of Nottingham’s School of Pharmacy’s TSAR (Tabletting Science and Anti-Stick Research) project... Read more

Editor's Blog